Protein kinase inhibitors targeting the ERK1 ERK2 pathway were observed to control deep infiltrating endometriosis progression (Ngo et al., 2010) and their role in endometriosis treatment has been explored in several studies (Santulli et al., 2015). The gene discussed is MAPK1; the disease is endometriosis.